| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 06/23/2005 | WO2005056580A1 Tetrapeptide regulating blood glucose level in diabetes mellitus |
| 06/23/2005 | WO2005056537A1 The glucagon-like peptide-1 receptor agonists, the preparation and the use of the same |
| 06/23/2005 | WO2005056036A2 Regulation of food preference using glp-1 agonists |
| 06/23/2005 | WO2005056035A1 Alga extract and sugar hydrolase inhibitor containing the same |
| 06/23/2005 | WO2005056034A1 Alga extract and lipase inhibitor containing the same |
| 06/23/2005 | WO2005056031A1 Lipase inhibitor |
| 06/23/2005 | WO2005030333A3 Novel derivatives of 4a,5,9,10,11,12-hexahydrobenzofuro[3a,3,2] [2]- benzazepine, method for the production thereof and use thereof in the production of medicaments |
| 06/23/2005 | WO2005005471A3 Use of dg153 secreted protein products for preventing and treating pancreatic diseases and/or obesity and/or metabolic syndrome |
| 06/23/2005 | WO2004041258A8 Cyclic nucleotide phosphodiesterase inhibitors, preparation and uses |
| 06/23/2005 | WO2003102163A8 Methods of diagnosing and treating diabetes and insulin resistance |
| 06/23/2005 | US20050137239 Thiazole derivatives |
| 06/23/2005 | US20050137216 Heterocyclic sodium/proton exchange inhibitors and method |
| 06/23/2005 | US20050137214 Inhibitors of cyclin-dependent kinases 4 (cdk4); treating proliferative disorders such as cancer; salt of 6-Acetyl-8-cyclopentyl-5-methyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-8H-pyrido[2,3-d]pyrimidin-7-one for example |
| 06/23/2005 | US20050137212 Hppars activators |
| 06/23/2005 | US20050137192 Use of compounds such as 4-bromo-9a-butyl-8-chloro-6-fluoro-7-hydroxy-1,2,9,9a-tetrahydro-3H-fluoren-3-one to treat depression |
| 06/23/2005 | US20050137167 Inhibiting FGF growth factor with heparins; antitumor agents; angiogenesis inhibitor; antidiabetic agent treating diabetic retinopathy; antiinflammatory agent; treating retrolenticular fibroplasia, psoriasis, restenosis after angioplasty and after coronary by-pass; chemical intermediates; drug delivery |
| 06/23/2005 | US20050137144 synergistic admnistration of a weight-loss promoting anticonvulsant of of zonisamide or topiramate, and a norepinephrine or dopamine agonist; hypotensive, antidiabetic, anticholesterol agents |
| 06/23/2005 | US20050137143 Such as 3-( beta -D-glucopyranosyloxy)-4-[(4-isopropoxyphenyl)-methyl]-1-isopropyl-5-methylpyrazole; for prevention/treatment of diabetes, diabetic complications, and/or obesity; sodium glucose transport protein inhibitors |
| 06/23/2005 | US20050137135 Novel analogues of glucose-dependent insulinotropic polypeptide |
| 06/23/2005 | US20050136502 Treatment of disorders associated with elevated blood glucose or blood pressure |
| 06/23/2005 | US20050136484 Method for screening agents for the treatment of diabetes |
| 06/23/2005 | US20050136465 Screening assays |
| 06/23/2005 | US20050136138 mixtures of extracts from plants and vegetables such as ginger or onions, used to reduce serum levels of phosphatides and triglycerides, as dietetics, antilipemic and anticholesterol agents; cardiovascular disorders |
| 06/23/2005 | US20050136133 Administering an anti-allergy composition of a wood-vinegar distilled solution, colorless and transparent |
| 06/23/2005 | US20050136041 Transgenic cell comprising nucleotide sequences coding erythropoietin and/or glucagon-like peptides for use in treatment and prevention of blood and metabolic disorders; somatic and germ cell gene therapy; tissue engineering |
| 06/23/2005 | US20050136030 with cholestyramine or colestipol; kit for treating obesity |
| 06/23/2005 | CA2561746A1 Methods and compounds for modulating triglyceride and vldl secretion |
| 06/23/2005 | CA2549355A1 The glucagon-like peptide-1 receptor agonists, the preparation and the use of the same |
| 06/23/2005 | CA2548918A1 Alpha-amino acid derivatives and use thereof as medicines |
| 06/23/2005 | CA2548899A1 Marine algae extract and lipase inhibitor containing the same |
| 06/23/2005 | CA2548742A1 Dpp-iv inhibitors |
| 06/23/2005 | CA2547911A1 Dietary non-essential amino acid tyrosine regulates the body weight of animals through regulating the animal appetite or food intake |
| 06/23/2005 | CA2547573A1 N-alkyl pyrroles as hmg-coa reductase inhibitors |
| 06/23/2005 | CA2547391A1 Novel benzimidazole and imidazopyridine derivatives and use thereof as a medicament |
| 06/23/2005 | CA2547381A1 Marine algae extract and glycosidase inhibitor containing the same |
| 06/23/2005 | CA2490218A1 Extracorporeal photopheresis in combination with anti-tnf treatment |
| 06/22/2005 | EP1544295A1 Salt-inducible kinases 2 and use thereof |
| 06/22/2005 | EP1544281A1 Fat composition |
| 06/22/2005 | EP1544208A1 Pyrazole derivative, medicinal composition containing the same, medicinal use thereof, and intermediate for production thereof |
| 06/22/2005 | EP1544194A1 4-(substituted aryl)-5-hydroxyisoquinolinone derivative |
| 06/22/2005 | EP1543824A2 Thiazole derivatives to counter advanced glycation |
| 06/22/2005 | EP1543158A1 Regulated aptamer therapeutics |
| 06/22/2005 | EP1543034A2 Treatment and prophylaxis with 4-1bb-binding agents |
| 06/22/2005 | EP1543024A2 Cyclic amp phosphodiesterase 4d7 isoforms and methods of use |
| 06/22/2005 | EP1543023A2 Secondary binding site of dipeptidyl peptidase iv (dp iv) |
| 06/22/2005 | EP1542980A1 5-aryltetrazole compounds, compositions thereof, and uses therefor |
| 06/22/2005 | EP1542978A1 Novel bio-active molecules |
| 06/22/2005 | EP1542976A1 Substituted 4-(indazol-3-yl)phenols as estrogen receptor (er) ligands and their use in the treatment of inflammatory diseases |
| 06/22/2005 | EP1542972A2 Cyclooxygenase- 2 selective inhibitors, compositions and methods of use |
| 06/22/2005 | EP1542966A1 Aromatic liver x-receptor modulators |
| 06/22/2005 | EP1542716A1 Growth hormone releasing peptides |
| 06/22/2005 | EP1542713A2 Skrp, astray, string, vacm associated with metabolic control |
| 06/22/2005 | EP1542712A2 Glp-1 formulations with protracted time action |
| 06/22/2005 | EP1542698A2 Modulation of matrix metalloproteinase (mmp) activity with aldosterone blocker(s) |
| 06/22/2005 | EP1469856A4 8-heteroaryl xanthine adenosine a sb 2b /sb receptor antagonists |
| 06/22/2005 | EP1372656B1 Pyrazolo[4,3-d]pyrimidinone compounds as cgmp pde inhibitors |
| 06/22/2005 | EP1320523B1 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseases |
| 06/22/2005 | EP1282619B1 Processes for the preparation of thiazolidinedione derivatives and intermediates |
| 06/22/2005 | EP1267915B1 Activated protein c for treating pancreatitis |
| 06/22/2005 | EP1196188B1 Vgf selective monoclonal antibodies and their use for treating vgf-related disorders |
| 06/22/2005 | EP1177200B1 Ligands for metabotropic glutamate receptors |
| 06/22/2005 | EP1171136B1 Immunomodulating compositions comprising urea derivatives for use in the treatment of inflammatory diseases |
| 06/22/2005 | EP1154774B1 Quinazoline derivatives as angiogenesis inhibitors |
| 06/22/2005 | EP1040111B1 Integrin receptor antagonists |
| 06/22/2005 | EP0866874B2 Process for the preparation of materials with a high content of isomers of conjugated linoleic acid |
| 06/22/2005 | CN1630720A Bifunctional fusion proteins with glucocerebrosidase activity |
| 06/22/2005 | CN1630710A Compositions including ammonia oxidizing bacteria and methods of using same |
| 06/22/2005 | CN1630709A Human glucagon-like-peptide-1 mimics and their use in the treatment of diabetes and related conditions |
| 06/22/2005 | CN1630664A Caspase-8 binding protein, its preparation and use |
| 06/22/2005 | CN1630657A Deazapurines and uses thereof |
| 06/22/2005 | CN1630656A Dihydropyrazolopyridine compounds and pharmaceutical use thereof |
| 06/22/2005 | CN1630650A Nitrogenous heterocyclic compound and medicine thereof |
| 06/22/2005 | CN1630649A Dihydrothiaphenanthrenecarbonylguanidines: composition, process of making, and use as medicament or diagnostic aid |
| 06/22/2005 | CN1630645A 5-HT receptor ligands and uses thereof |
| 06/22/2005 | CN1630644A Pyridine and pyrimidine derivatives |
| 06/22/2005 | CN1630642A Benzenesulfonamide derivatives |
| 06/22/2005 | CN1630639A Novel pyridine- and quinoline-derivatives |
| 06/22/2005 | CN1630636A Indoline derivatives and their use as 5-HT2 receptor ligands |
| 06/22/2005 | CN1630635A Amino alcohol derivatives or phosphonic acid derivatives and pharmaceutical compositions containing these |
| 06/22/2005 | CN1630629A 酯化合物及其医药用途 Ester compounds and pharmaceutical use |
| 06/22/2005 | CN1630532A Methods for prevention and treatment of gastrointestinal disorders |
| 06/22/2005 | CN1630526A Systems and methods for treating patients with processed lipoaspirate cells |
| 06/22/2005 | CN1630521A Oral compositions and methods for prevention, reduction and treatment of radiation injury |
| 06/22/2005 | CN1630520A Use of rosuvastatin (ZD-4522) in the treatment of heterozygous familial hypercholesterolemia |
| 06/22/2005 | CN1630516A Combinations of antibodies selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and other therapeutic agents |
| 06/22/2005 | CN1630515A Compounds active at the glucocorticoid receptor II |
| 06/22/2005 | CN1630510A Atorvastatin calcium in a pharmaceutical form, composition thereof, and pharmaceutical formulation comprising atorvastatin calcium |
| 06/22/2005 | CN1629288A Recombinant Baculovirus for expressing CTB and human insulin fusion protein and use thereof |
| 06/22/2005 | CN1628845A Compound medicinal formulation with bioactivity |
| 06/22/2005 | CN1628837A Pharmaceutical composition for treating coronary heart disease and angina pectoris and its preparing process |
| 06/22/2005 | CN1628829A Chinese medicine for treating hypertension, high blood fat and high blood sugar |
| 06/22/2005 | CN1628817A Paulswort and leech containing pills for lowering blood fat |
| 06/22/2005 | CN1628816A Process for preparing diabetes, piles and nephritis treating formulation |
| 06/22/2005 | CN1628786A Medicine for treating hyperlipemia |
| 06/22/2005 | CN1628782A Natural nutrient formulation with multiple vitamins and its preparation process |
| 06/22/2005 | CN1628769A Blood fat lowering and meridians dredging medicine and its preparation |
| 06/22/2005 | CN1628766A Formulation of 'Xuefu Zhuyu Decoction' and its preparation method |
| 06/22/2005 | CN1628760A Traditional Chinese medicinal formulation for treating cardiovascular and cerebrovascular disease |
| 06/22/2005 | CN1628751A Preparation method of ginseng fruit extractive and its medicinal usage for treating diabetes |
| 06/22/2005 | CN1628749A Eatable ants and its preparation method |